Shanti Spintex Reports Audited FY2026 Financials

Shanti Spintex's consolidated revenue stood at ₹704.21 crore for FY2026, with a net profit of ₹9.91 crore.
Standalone revenue was ₹682.81 crore, and standalone net profit was ₹4.49 crore.

Reader Takeaway: Consolidated growth masks standalone profit decline; acquisition strategy noted.

What just happened

Shanti Spintex Ltd announced its audited financial results for the fiscal year 2026. The company reported consolidated revenue of ₹704.21 crore and a consolidated net profit of ₹9.91 crore. On a standalone basis, revenue was ₹682.81 crore, while net profit stood at ₹4.49 crore.

In a significant corporate development, Shanti Spintex acquired 100% equity in Teesta Spintex Private Limited, effective May 9, 2025. Furthermore, the Board of Directors has approved the company's participation in Corporate Insolvency Resolution Processes (CIRP) through consortiums and bidding.

Why this matters

The results highlight a mixed performance. While the consolidated figures reflect overall group performance, including the newly acquired entity, the standalone performance shows a significant drop in profitability. Standalone net profit declined by 55.98% to ₹4.49 crore from ₹10.20 crore in FY2025. This indicates pressure on the core business's margins.

The acquisition of Teesta Spintex and the strategic move towards participating in CIRP signal the company's ambition for inorganic growth and expansion, potentially through distressed asset acquisitions. Investors will be keen to see how these initiatives impact future profitability.

The backstory

For the fiscal year 2025, Shanti Spintex reported standalone revenue of ₹709.94 crore and a standalone net profit of ₹10.20 crore. The current fiscal year's standalone results show a decline in both revenue (-3.82%) and a sharp fall in net profit (-55.98%). The acquisition of Teesta Spintex Private Limited is a recent addition to the company's structure.

What changes now

With the acquisition of Teesta Spintex, its financials are now included in the consolidated results, potentially boosting overall group revenue and profits. The approval for CIRP participation opens up new avenues for growth, but also introduces new risks and capital allocation considerations. The company's focus will likely shift towards integrating the new subsidiary and evaluating potential CIRP opportunities.

Risks to watch

The primary risk highlighted is the significant decline in standalone net profit, indicating potential challenges in the company's core operational efficiency or market conditions. Additionally, participation in CIRP processes involves inherent risks related to the complexity of distressed asset acquisitions, execution, and capital deployment.

Peer comparison

(Peer comparison data not available in the filing)

Context metrics (time-bound)

Standalone Net Profit comparison:
FY2026: ₹4.49 crore
FY2025: ₹10.20 crore
(–55.98% change)

Standalone Revenue comparison:
FY2026: ₹682.81 crore
FY2025: ₹709.94 crore
(–3.82% change)

What to track next

Investors should monitor the performance of the consolidated entity, particularly how the integration of Teesta Spintex affects overall profitability. Tracking the success of any CIRP bids and their contribution to the bottom line will be crucial. Management commentary on margin improvement for the standalone business will also be important.